Convatec Group Plc · LSE:CTEC
Convatec — Shareholder Meeting (May 2025)
11 slides from Convatec's shareholder meeting presentation, May 22, 2025
Slide 1: Strong start to the year, on track to hit our targets
22 May 2025 Strong start to the year, on track to hit our targets AGM trading update for the four months ended 30 April 2025
Slide 2: Disclaimer
Disclaimer For the purposes of this notice, “Presentation” means this document, its contents or any part of it, any oral presentation, any question or answer session and any written or oral material discussed or distributed before, during or after the Presentation meeting. This information, which do
Slide 3: Host
Host Jonny Mason Chief Financial Officer 3
Slide 4: Broad-based growth across all categories
Broad-based growth across all categories Jan-Apr 2025 FY25 guidance Organic revenue growth1 Strong start and on track to deliver targets. 6.7%2 5.5-7.0%2 excluding InnovaMatrix®2 Inc. InnovaMatrix®2 organic revenue growth1 was 6.2% Advanced Wound Care Growth led by North America & GEM. Slower start
Slide 5: Update on InnovaMatrix (c.3% Group revenue)
Update on InnovaMatrix® (c.3% Group revenue) • We welcome the second postponement of the LCDs Local Coverage Postponement improves until 1 January 2026 Determinations outlook • Uncertainty remains; engaged with key stakeholders • Revenue down YTD impacted by the uncertainty FY25 InnovaMatrix® Revenu
Slide 6: Strategic progress
Strategic progress Launches underway Scaling in new markets Driving simplification and productivity Gaining share in US Europe launch underway GEM to follow Global Quality & Operations Starting to launch in Europe in Q4 25 Gaining share in US, Europe & GEM Commercial Gaining share in US & Europe Str
Slide 7: Tightened FY25 guidance
Tightened FY 25 guidance Organic revenue • Guidance for each category remains unchanged: Previous 5-7% growth1 ex-InnovaMatrix®2 5.5-7.0% FY24: 7.7% • AWC: MSD excluding InnovaMatrix®; OC: MSD; CC: M/HSD; IC: HSD • Further operations, commercial & G&A productivity Adjusted operating Unchanged profit
Slide 8: Summary
Summary Strong start to 2025 • Broad-based growth across all categories; new product launches performing well • Some positive revenue phasing in the period in IC; will normalise through the year • Postponement of LCDs improves outlook for InnovaMatrix® Tightened FY25 financial guidance • 5.5-7.0% Gr
Slide 9: &
& 9
Slide 10: Appendix
Appendix 10
Slide 11: Strong track record of delivery
Strong track record of delivery Organic revenue growth1 Operating profit margin2 Earnings per share3 6 years of acceleration +350bps in previous 3 years +14% in 2024 21.5% 21.0% 21.2% 15.0c 15.2c 20.5% 7.7% 20.0% 20.2% 14.0c 7.2% 19.5% 19.4% 19.5% 13.0c 13.4c 5.6% 19.0% 5.3% 13.0c 12.6c 18.5% 4.2% 1